Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

doi:10.1016/j.ijantimicag.2020.106017

. 2020 Aug;56(2):106017.

doi: 10.1016/j.ijantimicag.2020.106017. Epub 2020 May 11.

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Affiliations

¹ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy. Electronic address: arturo.ciccullo@gmail.com.
² Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
³ Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy.
⁴ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Dipartimento di Medicina e chirurgia traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
⁵ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy.

PMID: 32437920
PMCID: PMC7211594
DOI: 10.1016/j.ijantimicag.2020.106017

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Arturo Ciccullo et al. Int J Antimicrob Agents. 2020 Aug.

. 2020 Aug;56(2):106017.

doi: 10.1016/j.ijantimicag.2020.106017. Epub 2020 May 11.

Affiliations

¹ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy. Electronic address: arturo.ciccullo@gmail.com.
² Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
³ Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy.
⁴ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Dipartimento di Medicina e chirurgia traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
⁵ Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Section of Infectious Diseases, Department of Safety and Bioethics, Catholic University of the Sacred Heart, Rome, Italy.

PMID: 32437920
PMCID: PMC7211594
DOI: 10.1016/j.ijantimicag.2020.106017

No abstract available

PubMed Disclaimer

Cited by

Neutrophil to lymphocyte ratio and in-hospital mortality among patients with SARS-CoV-2: A retrospective study.
Al-Mazedi MS, Rajan R, Al-Jarallah M, Dashti R, Al Saber A, Pan J, Zhanna KD, Abdelnaby H, Aboelhassan W, Almutairi F, Alotaibi N, Al Saleh M, AlNasrallah N, Al-Bader B, Malhas H, Ramadhan M, Brady PA, Al-Zakwani I, Setiya P, Abdullah M, Alroomi M, Tse G. Al-Mazedi MS, et al. Ann Med Surg (Lond). 2022 Oct;82:104748. doi: 10.1016/j.amsu.2022.104748. Epub 2022 Oct 1. Ann Med Surg (Lond). 2022. PMID: 36212733 Free PMC article.
Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India.
Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A, Malik PS, Sahoo RK, Rastogi S, Pramanik R, Batra A, Pushpam D, Sharma CK, Sharma V, Kataria B, Goyal K, Samaga S, Bothra SJ, Sharma A. Kumar A, et al. Indian J Med Res. 2022 May-Jun;155(5&6):546-553. doi: 10.4103/ijmr.ijmr_1703_21. Indian J Med Res. 2022. PMID: 36348601 Free PMC article.
Extracellular Oxidative Stress Markers in COVID-19 Patients with Diabetes as Co-Morbidity.
Kumar DS, Hanumanram G, Suthakaran PK, Mohanan J, Nair LDV, Rajendran K. Kumar DS, et al. Clin Pract. 2022 Feb 28;12(2):168-176. doi: 10.3390/clinpract12020021. Clin Pract. 2022. PMID: 35314591 Free PMC article.
Clinical Variants, Characteristics, and Outcomes Among COVID-19 Patients: A Case Series Analysis at a Tertiary Care Hospital in Karachi, Pakistan.
Ahsan T, Rani B, Siddiqui R, D'Souza G, Memon R, Lutfi I, I Hasan O, Javed R, Khan F, Hassan M. Ahsan T, et al. Cureus. 2021 Apr 29;13(4):e14761. doi: 10.7759/cureus.14761. Cureus. 2021. PMID: 34084685 Free PMC article.
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond.
Vuorio A, Kovanen PT. Vuorio A, et al. Front Pharmacol. 2021 Jan 19;11:579548. doi: 10.3389/fphar.2020.579548. eCollection 2020. Front Pharmacol. 2021. PMID: 33542685 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. Errata in: Lancet 2020;395:1038; Lancet 2020;395:1038. - DOI - PMC - PubMed
1. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106 doi: 10.1093/jnci/dju124. dju124. - DOI - PubMed
1. Società Italiana di Malattie Infettive e Tropicali (SIMIT). Vademecum per la cura delle persone con malattia da COVID-19. Edizione 2.0, 13 marzo 2020 [Handbook for the treatment of people with COVID-19 disease. Edition 2.0, 13 March 2020].http://www.simit.org/medias/1569-covid19-vademecum-13-03-202.pdf[accessed 27 March 2020].
1. Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020 Mar 17 doi: 10.1002/jmv.25767. [Epub ahead of print] - DOI - PMC - PubMed
1. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020 Mar 12 doi: 10.1093/cid/ciaa248. [Epub ahead of print] - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources

[1] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. Errata in: Lancet 2020;395:1038; Lancet 2020;395:1038. - DOI - PMC - PubMed

[2] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3. Errata in: Lancet 2020;395:1038; Lancet 2020;395:1038. - DOI - PMC - PubMed

[3] Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106 doi: 10.1093/jnci/dju124. dju124. - DOI - PubMed

[4] Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106 doi: 10.1093/jnci/dju124. dju124. - DOI - PubMed

[5] Società Italiana di Malattie Infettive e Tropicali (SIMIT). Vademecum per la cura delle persone con malattia da COVID-19. Edizione 2.0, 13 marzo 2020 [Handbook for the treatment of people with COVID-19 disease. Edition 2.0, 13 March 2020].http://www.simit.org/medias/1569-covid19-vademecum-13-03-202.pdf[accessed 27 March 2020].

[6] Società Italiana di Malattie Infettive e Tropicali (SIMIT). Vademecum per la cura delle persone con malattia da COVID-19. Edizione 2.0, 13 marzo 2020 [Handbook for the treatment of people with COVID-19 disease. Edition 2.0, 13 March 2020].http://www.simit.org/medias/1569-covid19-vademecum-13-03-202.pdf[accessed 27 March 2020].

[7] Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020 Mar 17 doi: 10.1002/jmv.25767. [Epub ahead of print] - DOI - PMC - PubMed

[8] Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li XM, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020 Mar 17 doi: 10.1002/jmv.25767. [Epub ahead of print] - DOI - PMC - PubMed

[9] Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020 Mar 12 doi: 10.1093/cid/ciaa248. [Epub ahead of print] - DOI - PMC - PubMed

[10] Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020 Mar 12 doi: 10.1093/cid/ciaa248. [Epub ahead of print] - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Affiliations

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources